Navigation Links
Peptimmune Announces Second Grant of a United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
Date:3/5/2010

CAMBRIDGE, Mass., March 5 /PRNewswire/ -- Peptimmune, Inc. a privately held biotechnology company, announced today the grant of US Patent Number 7,655,221 (the '221 patent) which protects the target product profile for its PI-2301 peptide copolymer for the treatment of multiple sclerosis, and other autoimmune diseases.

The '221 patent claims important treatment modalities for PI-2301 and related compounds.  "The '221 patent enhances the exclusivity for what we believe may become a very important therapy for the treatment of multiple sclerosis and other autoimmune diseases," stated Thomas P. Mathers, President & CEO of Peptimmune.


'/>"/>
SOURCE Peptimmune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Peptimmune Announces First Close of Series D Private Financing
2. Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
3. Peptimmune Presentations at Upcoming Events
4. Peptimmune Completes Phase Ib Study of PI-2301 in Multiple Sclerosis Patients, and Presentation at ECTRIMS 2009
5. Peptimmune to Collaborate on Dengue Virus Vaccine and Point-Of-Care Diagnostic With Two DOD Biomedical Research Facilities
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... has initiated coverage of Alliqua, Inc. (OTCQB: ALQA). ... manufacturing, and marketing proprietary products to serve the ... http://equitiesiq.com/reports/alliqua/ , In late 2012, Alliqua was ... which launched the company’s new strategy to become ...
(Date:1/14/2014)... 2014 In recent years, growing ... and methods in product development and promotion has ... the industry. This mistrust, fueled by concerns about ... been further fed by reports of spectacular fines ... activities, allegations of industry suppression of negative clinical ...
(Date:1/14/2014)... Cardiff, UK (PRWEB) January 13, 2014 ... leader with more than 20 years in the industry, ... and photonics . Hainsey will serve as the society’s ... have Dr. Hainsey join SPIE as our Technology Strategist, ... said Dr. Andrew Brown, SPIE Senior Director for Global ...
(Date:1/14/2014)... 2014 BioMedomics, Inc. , a ... POC diagnostic platforms and novel disease specific POC tests, ... round of financing netting a total of $690,000. The ... outside equity capital in the company. This group of ... in diagnostics companies and includes Tom Roberg who was ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2BioMedomics, Inc. Closes $690K Round of Financing 2
... the Trudeau Institute may help to explain why live ... protection. The research is published in this month,s ... entitled "Live attenuated influenza vaccine (LAIV) impacts innate and ... scientist Dr. Laura Haynes and her colleagues. "Our ...
... ARBOR, Mich.---A delicate balance of atomic forces can be ... size---an attribute that,s important for many nanotech applications but ... The same type of forces are at work ... inorganic supercluster structures in this research are in many ...
... ST. LOUIS, Aug. 23, 2011 Bunge North America, ... BG ), issued the following statement which can be ... "Bunge North America is aware from press ... prior conversations with Syngenta, we are surprised and disappointed that ...
Cached Biology Technology:Trudeau Institute announces a discovery in how FluMist elicits protection 2Engineers discover nanoscale balancing act that mirrors forces at work in living systems 2Bunge Responds to Syngenta Suit 2
(Date:4/16/2014)... up, and you cannot lift your upper eyelid. You walk ... eyes look straight when they are rolled down in the ... allow people a normal position of their head. In order ... this happens. , In a paper published in the April ... of Iowa researchers Bernd Fritzsch and Jeremy Duncan and their ...
(Date:4/16/2014)... Adam Arkin, director of the Physical Biosciences Division ... a biologist who is recognized as a leading ... networks and populations and their application to systems ... six recipients of the 2013 Ernest Orlando Lawrence ... E.O. Lawrence Award, the Department of Energy (DOE),s ...
(Date:4/16/2014)... Aktories and Dr. Panagiotis Papatheodorou from the Institute of ... of Freiburg have discovered the receptor responsible for smuggling ... into the cell. The TpeL toxin, which is formed ... gas gangrene and food poisoning. It is very similar ... the genus Clostridium . The toxins bind to ...
Breaking Biology News(10 mins):Researchers track down cause of eye mobility disorder 2Berkeley Lab's Adam Arkin wins 2013 Lawrence Award 2Berkeley Lab's Adam Arkin wins 2013 Lawrence Award 3Gate for bacterial toxins found 2
... give the Anne McLaren Memorial Lecture at the UK National Stem ... to screening for drugs that target stem cells. To begin with, ... for new drugs to promote wound healing and aid the use ... can also be applied to a wide range of stem cells, ...
... food source, with a global harvest now at 110 million ... But epidemics of infectious disease threaten this vital industry, including ... Perhaps even more worrisome: these infections can spread to wild ... escaping from them. Heart and skeletal muscle ...
... nanotechnology in the field of drug delivery has attracted ... holds great promise for the development of targeted, localized ... are affected. Such targeted-therapy methods would ... anticancer drugs are distributed throughout the body, attacking healthy ...
Cached Biology News:Top professor will report new way to discover drugs that aid regenerative medicine 2New virus may pose risk to wild salmon 2Researchers use nanoparticles to shrink tumors in mice 2Researchers use nanoparticles to shrink tumors in mice 3